Skip to main content

Michael R. Bristow

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

About Michael R. Bristow

Michael R. Bristow is recorded as Board Member at Oruka Therapeutics, Inc. (ORKA). Oruka Therapeutics, Inc. reported in an 8-K filed January 31, 2024 that Michael R. Bristow was appointed Director, effective January 30, 2024. The proxy statement of Oruka Therapeutics, Inc. reports total compensation of $358,800 for Michael R. Bristow in fiscal 2022, including a base salary of $345,000. Disclosed compensation is on record for 5 fiscal years.

“Dr. Michael R. Bristow and Mr. Robert E. Conway, to the Board for a three-year term ending at the 2026 Annual Meeting of Stockholders”
Oruka Therapeutics, Inc. Form 8-K, filed January 31, 2024 · Read the filing

Summary generated from SEC filings and earnings-call records held by Equibles.

Affiliation history

Recorded current and former roles; source labels appear when available.

Company network

Recorded roles and call appearances connecting this person to public companies.

Leadership on record at Oruka Therapeutics, Inc.

Other people whose current roles at this company are on record from its filings.

Executive compensation

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year Company Salary Total
2022 Oruka Therapeutics, Inc. (ORKA) $345,000 $358,800
2021 Oruka Therapeutics, Inc. (ORKA) $343,431 $526,513
2020 Oruka Therapeutics, Inc. (ORKA) $286,083 $1,061,587
2019 Oruka Therapeutics, Inc. (ORKA) $284,328 $296,151
2018 Oruka Therapeutics, Inc. (ORKA) $304,219 $320,490

Recent activity

Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.